Microsystems engineering offers the tools to develop highly sophisticated miniaturized implants to interface with the nervous system. One challenging application field is the development of neural prostheses to restore vision in persons that have become blind by photoreceptor degeneration due to retinitis pigmentosa. The fundamental work that has been done in one approach is presented here. An epiretinal vision prosthesis has been developed that allows hybrid integration of electronics on one part of a thin and flexible substrate. Polyimide as a substrate material is proven to be non-cytotoxic. Non-hermetic encapsulation with parylene C was stable for at least 3 months in vivo. Chronic animal experiments proved spatially selective cortical activation after epiretinal stimulation with a 25-channel implant. Research results have been transferred successfully to companies that currently work on the medical device approval of these retinal vision prostheses in Europe and in the USA.
Introduction
More than one million persons are legally blind in the USA, Australia and Europe (Javaheri et al 2006) . Despite enormous efforts and advances in clinical treatment of eye diseases, there is no established method to prevent or cure degenerative processes in the eye, such as age-related macula degeneration or retinitis pigmentosa. The restoration of sight after visual impairment and loss of the vision sense is a particular challenge in neural prostheses that more than 20 research groups and companies are facing worldwide (Hessburg and Rizzo 2007) . More than a million sensory cells, the rods and cones, act as transducers in the healthy retina. The light which is projected onto the retina is transduced into electrical potentials. They were transformed into pulses that were processed over the different cell layers within the retina. These pulses were conducted over the optic nerve and the lateral geniculate nuclei to the visual cortex. Depending on disease or trauma, visual impairment and blindness occur for different reasons which have to be taken into account when an implantation site and a neural prosthesis have to be chosen.
In 1929, Foerster showed for the first time that the electrical stimulation of the visual cortex led to the perception of light sensations in the shape of points, so-called phosphenes (Foerster 1929) . Nowadays, research focuses mainly on the development of vision prostheses for patients with retinitis pigmentosa, a hereditary disease in which the sensory cells of the retina degenerate. The visual field decreases succeedingly from the periphery leading to tunnel vision and finally to complete visual impairment (blindness). Even though the photoreceptors degenerate in retinitis pigmentosa, the ganglion cell layer and at least partially some structures from the amacrine and bipolar cell layer are preserved (Stone et al 1992 , Santos et al 1997 , Humayun et al 1999 .
Worldwide, 1.5 million individuals suffer from retinitis pigmentosa or other diseases that cause visual impairment up to complete vision loss including retinal degeneration by glaucoma and loss of visual pathways and relay stations due to hereditary or cancerous nerve destruction. Probably, those patients might also benefit from vision prostheses in the long term. Depending on the disease or trauma, three different implantation sites are currently under investigation (Alteheld et al 2004) : the retina, the optical nerve and the visual cortex. Comprehensive summaries from different points of view give a deep insight into the vision prosthesis field (Margalit et al Photoreceptors transfer light into electrical potentials which are pre-processed in the four layers (ganglion/amacrine/bipolar/ horizontal cells) above before the ganglion cell axons guide the pulse coded action potentials via the optic nerve to higher visual structures.
2002, Alteheld et al 2004 , Veraart et al 2004 . The longterm goal of all the vision prostheses' research might be the restoration of 'normal' vision, but the short-term goal must be a spatio-temporal resolution of the implant so that the patient is able to navigate in an unknown environment. Otherwise, the implant will not be accepted and commercialized for a large number of patients. First, the implants have to prove their applicability. Accurate rehabilitation assessment should be addressed to have objective measures for the comparison of different concepts and their ability to restore vision to some extent. This paper summarizes the fundamental steps during design and development of a micromachined epiretinal vision prosthesis within the EPI-RET consortium in Germany (Eckmiller 1997 , Meyer 2002 with special emphasis on the electrode-substrate co-design, the evaluation of the cytotoxicity and hybrid assembly of the system. The accompanying pilot experiments on animals were summarized that finally led to a spatiotemporal cortical activation after retinal stimulation with a wireless implant.
Materials and methods

System concept of a micromachined epiretinal vision prosthesis
Worldwide, scientific research groups and companies work on the development and commercialization of retinal vision prostheses. The different approaches have to take into account the anatomical restrictions of the eye globe and the physiology of the human retina (figure 1). Light passes through the lens and the retinal cell layers. Photoreceptors transform light into electrical potentials which are pre-processed in the four layers above before the ganglion cell axons guide the pulsecoded action potentials via the optic nerve to higher visual structures. In retinitis pigmentosa, the photoreceptors and cells of the adjacent layers degenerate. Retina prostheses simulate the physiological function of the deceased receptor cells and stimulate the visual system on a very proximal level. Thereby, they benefit from the retinotopic organization of the retina and the further information processing of the entire visual pathway (Margalit et al 2002) . The developments in which the electrode arrays have to be placed under the retina (subretinal) or on the retina (epiretinal) have yet to become feasible by the degree of miniaturization made by means of microsystem technology. Depending on the implantation site, the system concept is quite different (figure 2). Subretinal approaches place microphotodiodes underneath the retina to excite the remaining cells (Zrenner et al 1999 , Chow et al 2004 . Research groups and companies in Australia, the USA and Germany work on an epiretinal vision prosthesis, in which electrodes are placed on the ganglion cell layer (Walter et al 2005 , Hornig et al 2005 , Kerdraon et al 2002 , Humayun et al 2003 . These vary in their details but are identical in their general components: a camera, a transmission unit for data and energy and the implant with an electrode array. The German EPI-RET team focused from 1995 to 2003 on the development of an epiretinal vision prosthesis for ganglion cell stimulation (figure 3) that consisted of an external CMOS camera with a high dynamic range that sends the pictures of the environment to a so-called retina encoder (Eckmiller 1997) . It translated the figures into spatio-temporal stimulation patterns that match the input of the ganglion cell layer in an intact retina. These data were transmitted via an inductive telemetric link to the retina implant. The energy from the transmission powered Figure 3 . Sketch of an epiretinal vision prosthesis (courtesy of the EPI-RET consortium, Germany). A camera takes pictures from the environment which were transferred into spatiotemporal trains of stimulus pulses with the help of a retina encoder. These data and the energy to operate the implant are transferred via an inductive link to the implanted microsystem. The receiver decodes the information and addresses the stimulation electrodes via an integrated ribbon cable and stimulus circuitry. the electronic circuitry. Data were decoded and a stimulator chip selected the appropriate electrode for stimulation out of an array that directly lies on the retina.
Considerable research efforts are also under way in Japan, Korea and Australia toward a super-choroidal electrode placement approach with promising results (Wong et al 2009 , Sakaguchi et al 2004 , Yamauchi et al 2005 , Kim et al 2009 . System design and components are comparable to the epiretinal approaches but vary, of course, in their details.
Material selection for substrate and encapsulation
Vision prostheses as one application of neural prostheses have to fulfill different requirements for acute and especially for chronic implantation with respect to their biocompatibility (Williams 2008) . They have to be stable in the physiological environment, i.e. no degeneration should occur. All parts of an implant have to be non-toxic for the cells or have to be encapsulated with a non-toxic material that serves as a diffusion barrier for these substances preventing elusion into the body. Conducting materials for interconnects and electrodes should have a low tendency to create corrosion products in a physiological environment without a voltage bias and during stimulation with current pulses. Common metals that satisfy these electrochemical requirements are gold, platinum and iridium. They can be deposited in thin-film technology and structured with micromachining techniques. Additionally, the devices have to be designed 'biomechanically safe', i.e. with a good structural biocompatibility. A 'smooth' geometry might help to prevent induced nerve trauma by sharp edges and corners. Furthermore, the material itself should be light weight to reduce inertial forces and torques with the surrounding tissue to a minimum. The ideal material combines excellent surface biocompatibility with proper mechanical characteristics while applying micromachining technologies. For the development of highly flexible, ultra-light weight, multichannel microelectrodes, we have chosen polyimide as a material for several reasons. Polyimides are wellknown materials for a wide range of applications. It was proved as a non-toxic material in biomedicine (Akin et al 1994) and was used for neural implants (Richardson et al 1993) . Polyimide Pyralin PI 2611 (HD Microsystems) was chosen as a substrate and insulation material (figure 4). Compared with silicon and silicon-based insulation layers (SiO 2 , Si 3 N 4 ), PI 2611 has a similar insulation resistance and dielectric strength at a lower density and a higher flexibility (table 1) . It can be processed with standard clean room equipment for microelectronics. Hybrid assemblies of polyimide-based substrates with integrated interconnections, silicon microelectronic circuitry and standard electronic components are possible. The hybrid approach allowed relatively low development time and lower costs than monolithically integrated silicon microsystems envisioning small and medium-sized volume fabrication which was reasonable for the first generation of vision prostheses.
Electrode-substrate co-design
We developed a process technology which overcame the 'classical' separation of the substrate and insulation layers and allowed us to integrate interconnects and electrodes (Stieglitz et al 2000a) . Arbitrary device perimeters and electrode substrates became feasible. A short description of the process (figure 5) with multilayer metallization for electrodes and interconnect lines visualizes the principal design and structure of the multichannel devices. At first, a 5 μm thick layer of polyimide resin (Pyralin PI 2611, HD Microsystems) was spun onto a silicon wafer which serves as a support structure during the whole process ( figure 5(a) ). The polyimide was cured in a polyimide oven. The first metallization layer of platinum for connection pads, interconnect lines and electrode sites was deposited by sputtering and structured with a liftoff technique (figure 5(b)). A second polyimide layer with a thickness between 3 μm and 5 μm was spun on and was cured to insulate the first metallization layer (figure 5(c)). The second metallization layer was sputter deposited and structured for a second set of electrode sites, interconnection lines and connection pads (figure 5(d)). Finally, a polyimide layer of 5 μm was spun on for the top insulation. An aluminum etching mask was deposited and structured with wet etching to define electrode sites and the outer geometry of the devices (figure 5(e)). Reactive ion etching (RIE) was used to open the electrode sites and connection pads and to separate the devices by etching the devices perimeter down to the support wafer (figure 5(f)). Finally, the devices were mechanically peeled off the wafer with a pair of tweezers (figure 5(g)). No release layer was used for this last step to separate the devices from the support wafer.
Biocompatibility testing of the micromachined substrates
In parallel research lines to the device development, the biocompatibility of the newly developed devices was tested. Cytotoxicity studies of the used materials that have not been certified 'medical grade' were conducted to evaluate their surface biocompatibility. Chronic animal studies were performed to obtain results with respect to structural biocompatibility, i.e. material-tissue interaction. Further, these results could be used to estimate the biostability of the implants in the eye.
Cytotoxicity testing.
The cytotoxicity of the materials and the residues of the process technology agents was tested in the cell culture laboratories of the Fraunhofer Institute for Biomedical Engineering (St Ingbert, Germany) according to ISO 10993 (ISO 10993-1 1997) on L929 mouse fibroblasts (ISO 10993-part 5: Tests for cytotoxicity: in vitro methods: part 12. Sample preparation and reference materials) and additionally on the neuroblastoma cell line OLN 93. Direct contact tests were performed to evaluate the morphology and viability of the cells. Quantitative tests were performed on the polyimides as extract testing. Cell vitality was investigated via the reduction of tetrazolium salts (WST-1 test kit, Boehringer Mannheim, Mannheim, Germany), and the cell proliferation was followed by incorporation of 5-bromo-2 -deoxyuridine (BrdU) into the DNA of the cells (Cell Proliferation ELISA BrdU, Boehringer Mannheim, Mannheim, Germany) by means of an ELISA reader. Positive and negative reference materials have been included in all test systems. As a negative material, we used polypropylene tubing (Rau-PP 146, article no. 068691, Rehau AG+CO, Rehau, Germany) and a pure media control. 2-Hydroxyethylmethacrylate (HEMA, 1 vol.%) served as positive control substance. Cell culture media were chosen adequate for the different cell lines: RPMI with NaHCO 3 was used for the L929 cells and DMEM was used for the OLN 93 cells. The media were supplemented with 10% (v/v) heat-inactivated fetal calf serum and the antibiotics penicillin/streptomycin (500×), lyophilisate (100 IU ml −1 ) and streptomycin (100 μg ml −1 ). All test samples and the negative control materials were sterilized in an autoclave (121
• C, 20 min). For each liquid, extracts were prepared in accordance with ISO 10993-12 'Biological evaluation of medical devices. Sample preparation and reference materials'. The cells were cultivated for 48 h in 96-well microtiter plates (10 000 cells per well) for extract testing and in plastic petri dishes (35/10 mm) for the direct contact test (100 000 cells per petri dish). Six pieces of 1 cm 2 from each material under test were used per milliliter of cell culture medium. The extracts were incubated for 24 h at a temperature of 37
• C in a humid atmosphere ( 95% relative humidity) containing 5% CO 2 for the OLN 93 and 7.5% CO 2 for the L929 cells, respectively. The cell culture medium was replaced by 100 μl extract and incubated for a further 24 h. Each extract was tested threefold. For direct contact tests, the materials under test were directly placed on the cell layer. They were incubated for a further 24 h with the above-mentioned parameters (temperature, CO 2 , humidity). Tests were done again threefold. The morphology of the subconfluent monolayer (70-90% of the area) was checked before testing.
2.4.2.
Chronic behavior of passive micromachined implants. The structural biocompatibility was evaluated in chronic implantations with non-functional stimulation arrays. Electrodes were implanted up to 6 months on the retinal surface using retinal tacks. Visually evoked potentials (VEP) by flashlight stimulation were recorded over the implantation time on the occipital part of the skull (one channel recordings) to monitor possible damage of the retina, e.g. due to contact force of the array on the retina. The measurement did not deliver information about spatial distribution of the VEP with respect to different parts of the implanted electrode array, since only the integral signal was recorded. After explantation, the retinas were investigated with respect to the material-tissue interaction and possible reactions on the morphology of the retina (Walter et al 1999) .
Acute stimulation of the retina
The implantation procedure for stimulation arrays as well as chronic implants is demanding but technically feasible. After a training phase, the implants were placed long-term stable (Walter et al 1999) . The spatio-temporal resolution of cortical excitation after retinal stimulation (Wilms et al 2003) has been proven by microelectrode recordings and stimulation but not with planar electrode arrays. First, evoked potentials were recorded from the skull of rabbits after electrical stimulation (100 μs pulse width, 100 μA amplitude) of the retina with a polyimide array (Walter et al 1998) . For a series of acute stimulations in a cat model, a stimulation array with a plug to interface with stimulus generators was chosen (figure 9). The measurement setup allowed the recording of compound nerve potentials from the optical tract and optical recording of the visual cortex (Stieglitz and Meyer 2006) to correlate stimulation sites and parameters with cortical activation (Eysel et al 2003) .
Design and hybrid assembly of a wireless implant
The first version of this retinal vision prosthesis was intended to be evaluated mainly in subchronic applications (<30 days) to investigate spatio-temporal excitation of cortical activity after retinal stimulation. For this limited time period, nonhermetic encapsulation techniques were chosen with parylene as a first material with little water permeation and silicone rubber as second material to form an intraocular lens. In parallel to the development of an inductively powered implant, a test system was developed to investigate the integrity of the parylene encapsulation without the need to assemble a system with sophisticated microelectronic circuitry.
Test system for encapsulation tests.
The functional integrity of the polyimide-parylene-silicone encapsulation was evaluated in a simple test device but with the same geometry after similar implantation procedure in cats (Schanze et al 2007) . Four photodiodes were used as power source for a one-channel stimulator that was driven by infrared light. They were assembled and encapsulated with parylene and housed in an artificial intraocular lens made of silicone rubber. The implantation time was limited to 3 months. The implanted test systems remained functional and proved the biostability of the encapsulation approach (Schanze et al 2007) .
Development of inductively powered wireless systems.
The wireless implant was designed as a fully implantable system (figure 11). The receiver for data and energy was to be assembled in an artificial intraocular lens; a thin ribbon cable interconnected the receiver with the stimulator chip and the stimulation electrodes (Stieglitz et al 2000b) . The system consisted of a substrate with integrated electrodes, a coil, a capacitor, a diode and two application-specific integrated circuits (ASICs) for data decoding and stimulus pulse forming, respectively (figure 12(a)) (Stieglitz et al 1997 (Stieglitz et al , 1999 .
The flexible polyimide foils were used as substrates for assembly and hybrid integration of the retina implant systems. The discrete components (wire coil, capacitor, diode) were mechanically fixed and electrically contacted to the substrate by hand. Integrated microelectronic circuitry demanded a technology that allowed a high integration density of contact pads. Especially for the assembly of standard or custom-made microelectronic dice to our thin polyimide foils, we developed the MicroFlex interconnection technique (Meyer et al 2001) . This stud ball technique used ball-wedge bonding equipment. Gold balls were pushed through holes in the connection pads of the flexible substrate to the corresponding pads of an integrated circuit that has been aligned under the substrate. The deformation of the gold ball gives mechanical stability and an electrical connection between bond ball, interconnection pad and chip pad with high reliability. The devices were coated with parylene, which has become the generic name of poly-para-xylylenes. We used parylene C with one chlorine atom on the benzene ring that has favorable properties due to its lowest permeability to moisture and corrosive gases (Noordegraaf 1997) . Additionally, the system was encapsulated with silicone (polydimethylsiloxane, PDMS) to reach two aims: a further protection of the electronics and to allow the stimulator's implantation into the eye as an artificial intraocular lens. We used Sylgard R 184 (Dow Corning Corp., Midland, MI) and brass casting tools (moulds) for reproducible encapsulation in a vulcanization process (Stieglitz et al 2004) .
Each implant received a serial number on the receiver part for its identification after implantation. Test pads on the substrates allowed system test after assembly and before encapsulation. The hybrid assembly of the receiver comprised several manual steps, but finally, a yield of more than 90% was reached ( figure 12(b) ). After encapsulation with parylene C and silicone rubber, the final vision prostheses were electrically tested and proved to be functional. These microimplants ( figure 12(c) ) with a length of approximately 30 mm were finally passed to our clinical partners for chronic implantation in cats.
Results
Electrodes
In the first design, several test structures without electrode metallization were produced to evaluate the flexibility of figure 6 ). The handling properties for an implantation were evaluated by a team of retina surgeons. The stiffness was too high in most of the 'solid' or 'mesh-shape' designs, even though diffusion of nutrients would be possible. Spiral designs were too pliant to be manageable during implantation. Rings with s-shaped interconnects (figure 6, right) combined flexibility and stability in an adequate manner. This design also allows the adaptation of the planar device to a spherical shape to some extent if it is fixed to the eye globe with a retinal tack, for example. These investigations resulted in a design of a stimulation device (figure 7, table 2) for acute studies. The design comprised an active area with up to 24 concentric, bipolar electrodes (figure 8), long integrated interconnects, and a contact array to interface via an additional substrate with plugs ( figure 9 ) and conventional or custom-made stimulation equipment. The concentric electrodes were realized in a two-metallizationlayer process that has been described above. Platinum was used for the thin-film electrodes, interconnects and pads.
Biocompatibility testing
3.2.1. Cytotoxicity. The cytotoxicity tests of the polyimide Pyralin PI 2611 according to ISO showed no toxicity, neither with the L929 nor with the OLN 93 cell lines (Stieglitz et al 2009) . From this point of view, this polyimide can be stated as being a biomaterial. The quantitative extract tests indicated excellent compatibility with a slight increase in the cell metabolism and a slight decrease in the DNA synthesis rate in the O 2 /CF 4 surface modification of the devices in comparison to the oxygen modification or no modification (figure 10). Cell vitality (WST-1 test) and DNA synthesis rate (BrdU-test) were in the range of the negative (i.e. nontoxic) control material. The direct contact tests showed excellent viability of the cells on the unmodified polyimide, and no alterations in morphology were observed on the O 2 /CF 4 modified surface. Oxygen surface modification resulted in better proliferation of the cells (Stieglitz et al 2009) .
The studies presented here with regard to the cytotoxicity of the materials were coincident with studies from other groups. In a large and comprehensive study on implant material biocompatibility in the brain, the widespread materials such as platinum, gold, aluminum, ceramics and silicon proved to be completely non-reactive (Stensaas and Stensaas 1978) .
Polyimides proved to be a non-toxic biomaterial for neural implants (Richardson et al 1993) in chronic studies. The in vitro cytotoxicity of PI 2556 was investigated and proven (Haggerty and Lusted 1989) in coincidence with our own results (Stieglitz et al 2009) . The cytotoxicity of parylene C was also investigated with the same test methods including surface modifications to vary the surface energy. It also obtained good results in direct and extract tests, especially with the activated surfaces (Stieglitz 2004) .
Structural biocompatibility.
The chronic behavior of the material-tissue interface is an indicator of the structural biocompatibility. The thin and flexible polyimide sheets of the electrode arrays did not harm the retina and neither caused any morphological changes in the retinal layers nor changed the latency or amplitude of visually evoked potentials in the operated eye in comparison to control measurements (Walter et al 1999) .
Cortical excitation after acute retinal stimulation
The first stimulation experiments in rabbits proved successful cortical activation after retinal stimulation with micromachined electrodes (Walter et al 1998) . Electrical stimulation of the retina with 25 polar electrode arrays (figure 9) that have been driven via cables passing the eyewall led to optic tract field potentials at thresholds between 4 μA and 78 μA at a pulse width of 250 μs (Eysel et al 2003) . Optical imaging in the visual cortex showed a precise twodimensional cortical retinotopy. The peaks of intrinsic activity were well separated with an activity that was equivalent to a visual resolution of 1.25
• at 2 • retinal eccentricity (Eysel et al 2003) . Charge per phase during stimulation was between 1 nC and 25 nC, i.e. charge density was between 250 μC cm −2 and 6.0 mC cm −2 per pulse. These values exceed the safe maximum charge injection limits of platinum (Veraart et al 2004) . Depending on the electrode technology and the way to calculate the electrodes surface, i.e. geometrical or the 'real' (electrochemical) surface, safe charge injection capacities vary from 40 μC cm −2 geometric (Donaldson and Donaldson 1986) to about 400 μC cm −2 electrochemical area for platinum (Brummer and Turner 1977) . The charge injection capacity of sputtered iridium oxide films (SIROF) varies with the deposition parameters, their thickness and the pulse parameters, but peak values of up to 9 mC cm −2 are feasible with stable layers up to 6 mC cm −2 (Cogan et al 2009) . However, even with larger electrode surfaces by increased roughness or other electrode material like iridium oxide, the long-term stability of the electrodes must be ensured and tissue damage due to the stimulation has to be prevented (Veraart et al 2004) that might occur at maximum values obtained in these acute experiments. In our case, the electrode-tissue contact in the acute setting might not have been tight enough at the electrodes in the periphery of the array and at the cable side. Electrodes closer to the center of the array corresponded to the lower charge injection values.
Evaluation of cortical activation after retinal stimulation with a wireless implant
Results from implantations in cats demonstrated successful local cortical activation generated by a retinal prosthesis which was completely implanted into the eye without any cable connection passing through the eyewall and driven by a transponder system for energy and signal. The cortical activation was achieved in the expected and retinotopically correct cortical area with a spatial extent corresponding to about 2.5
• of visual angle in the area centralis projection in area 18 of the cat (Walter et al 2005) . Because of the much larger magnification factor in humans, this represents a very conservative estimate of possible spatial resolution for an application in blind human subjects that may lead to visual percepts useful for gross pattern recognition and orientation.
After these first results, larger studies have to be conducted to investigate complex stimulation patterns, the long-term stability of the stimulation thresholds and the biostability of the materials and implants.
Conclusions
If anybody had asked laypersons or professionals 15 years ago, no one would have promised to be in human clinical studies with vision prostheses today. Nowadays, biomedical microtechnologies offer powerful tools to realize implants for neural prostheses in many fields. Due to the advances in the fabrication of flexible, highly integrated microsystems, the development of visual prostheses acting on various levels of the visual system became a realistic option in the future treatment of currently untreatable conditions leading to blindness. However, visual prostheses will not restore normal vision, at least not in the near future. The first generations of vision prostheses are expected to provide better quality of life for blind persons, e.g. for navigation in unknown environment without the help of sticks or dogs.
So far, wireless (mainly inductive) energy supply and data transmission systems have been integrated into micromachined retinal vision prostheses. Spatially selective cortical responses were reported in animal models and in first patients reported on stable phosphene perception (for an overview, see e.g. Stieglitz and Meyer (2006) ). Start-up companies in the USA (Second Sight: http://www.2-sight.com) and Germany (Retina Implant: http://www.retina-implant.de, Intelligent Medical Implants: http://www.imidevices.com, EPI-RET: http://www.epiret.de) are in the commercialization phase of the research results and are conducting clinical trials on humans and working on the medical device approval of the devices. However, the feedback of the first patients with chronic vision prostheses will guide us on how to proceed in research to bring vision prostheses into clinical practice. Only patients will tell us whether electrically elicited sensations can really be called vision or not.
